Stay updated on Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page shows updated last-update dates, reflecting maintenance of the record; no substantive study content appears to have changed.
    Difference
    0.2%
    Check dated 2026-04-05T06:45:00.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added the disease term 'Squamous cell carcinoma of the head and neck' to broaden the study context. Added a Resources link to the Genetic and Rare Diseases Information Center for patient information.
    Difference
    0.1%
    Check dated 2026-03-29T00:43:35.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T19:07:13.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2026-03-14T11:37:51.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page now lists revision v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T04:59:59.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    - Added sponsor/institution references and a 'Helpful Links Provided by' section in the page footer (Moffitt Cancer Center Clinical Trials website, H. Lee Moffitt Cancer Center and Research Institute).
    Difference
    0.1%
    Check dated 2026-02-28T00:44:39.000Z thumbnail image

Stay in the know with updates to Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.